First Manhattan’s Ginkgo Bioworks DNA Stock Holding History

First Manhattan’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-828	Closed	-$59.9K	–	1464
2023 Q3	$59.9K	Hold	828	–	–	﹤0.01%	833
2023 Q2	$61.6K	Hold	828	–	–	﹤0.01%	847
2023 Q1	$44K	Hold	828	–	–	﹤0.01%	932
2022 Q4	$55.9K	Sell	828 -750	-48%	-$69K	﹤0.01%	924
2022 Q3	$196K	Buy	+1,578	New	+$188K	﹤0.01%	695
2022 Q1	–	Sell	-250	Closed	-$83K	–	1611
2021 Q4	$83K	Buy	+250	New	+$119K	﹤0.01%	900

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Manhattan's DNA Position: Q4 2023 in Review

First Manhattan sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 828 shares — an estimated $59.9K sold.

First Manhattan first reported a position in DNA in Q4 2021 and held it in 6 quarters. The position peaked at $196K in Q3 2022. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

First Manhattan reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
First Manhattan sold 828 Ginkgo Bioworks shares in Q4 2023, an estimated $59.9K.
First Manhattan first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 6 quarters.
First Manhattan's Ginkgo Bioworks position peaked at $196K in Q3 2022.
342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on First Manhattan's 13F filing for Q4 2023, filed 13 Feb 2024.